Literature DB >> 6170299

Dissociation of histamine release and clinical improvement following treatment of acquired cold urticaria by prednisone.

A K Black, T M Keahey, R A Eady, M W Greaves.   

Abstract

1 Corticosteroids are known to suppress evoked histamine release from human skin in vitro. Therefore the effect of prednisone, on cold evoked histamine release and clinical response was studied in six patients with acquired cold urticaria. 2 Following cold challenge all six patients developed an immediate urticarial response of the forearm and elevation of histamine levels, measured by superfusion cascade bioassay of the venous blood draining the forearm. 3 After treatment with prednisone, in an oral dose of 20-25 mg for 1 to 5 days, a suppression of evoked histamine release occurred in all but one patient. However, there was no corresponding decrease of erythema or oedema, though pruritus was improved in most patients. 4 The lack of clinical improvement in erythema and oedema, despite reduction in histamine levels, suggests that histamine may not be the principal mediator of the vascular response to cold challenge in acquired cold urticaria.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170299      PMCID: PMC1401800          DOI: 10.1111/j.1365-2125.1981.tb01221.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Histamine, hormones, and hypersensitivity.

Authors:  B ROSE
Journal:  J Allergy       Date:  1954-03

2.  Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge.

Authors:  S I Wasserman; N A Soter; D M Center; K F Austen
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  Stable low temperature source to test for cold urticaria.

Authors:  J S Curnow
Journal:  Med Biol Eng Comput       Date:  1978-03       Impact factor: 2.602

4.  Glucocorticoid inhibition of antigen-evoked histamine release from human skin.

Authors:  M W Greaves; V M Plummer
Journal:  Immunology       Date:  1974-09       Impact factor: 7.397

5.  The metabolism of histamine in a case of cold urticaria.

Authors:  G Granerus; S E Svensson; H Wetterqvist; T White
Journal:  Acta Allergol       Date:  1969-11

6.  In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling.

Authors:  A P Kaplan; M A Beaven
Journal:  J Invest Dermatol       Date:  1976-09       Impact factor: 8.551

7.  Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.

Authors:  N A Soter; S I Wasserman; K F Austen
Journal:  N Engl J Med       Date:  1976-03-25       Impact factor: 91.245

8.  Assessment of tissue fluid histamine levels in patients with urticaria.

Authors:  A P Kaplan; Z Horáková; S I Katz
Journal:  J Allergy Clin Immunol       Date:  1978-06       Impact factor: 10.793

9.  Induced tolerance in cold urticaria caused by cold-evoked histamine release.

Authors:  C B Bentley-Phillips; A K Black; M W Greaves
Journal:  Lancet       Date:  1976-07-10       Impact factor: 79.321

10.  Cold urticaria. Dissociation of cold-evoked histamine release and urticara following cold challenge.

Authors:  T M Keahey; M W Greaves
Journal:  Arch Dermatol       Date:  1980-02
View more
  2 in total

Review 1.  Chronic urticaria: aetiology, management and current and future treatment options.

Authors:  Martina M A Kozel; Ruth A Sabroe
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Diagnosis and management of cold urticaria in cryoablation of atrial fibrillation: a case report.

Authors:  Friederike Cordes; Christian Ellermann; Jan Ehrchen; Hansjoerg Ullerich; Lars Eckardt
Journal:  Eur Heart J Case Rep       Date:  2019-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.